Monthly Archives: November 2013

An Analysis With Serious Flaws

In May we discussed a recently published systematic review of DOT. Andrew Nunn and Patrick Phillips wrote to the journal highlighting their concerns. Here is a link to the table of contents for the edition of the journal in which their letter was published (alongside several others with additional concerns and comments) and a rather disappointing response from the authors: http://cid.oxfordjournals.org/content/57/7.toc.

Advertisements

Leave a comment

Filed under Uncategorized

Results from a randomised controlled trial in India looking at shortening treatment with gatifloxacin or moxifloxacin

Please join us on 12th November when Patrick Phillips will present the results of an RCT in India looking at shortening treatment with gatifloxacin or moxifloxacin and comment on the results of  OFLOTUB presented in Paris.

Presenter: Patrick Phillips

Chair: TBC

Paper: Jawahar, M. S., V. V. Banurekha, et al. (2013). “Randomized clinical trial of thrice-weekly 4-month moxifloxacin or gatifloxacin containing regimens in the treatment of new sputum positive pulmonary tuberculosis patients.” PLoS One 8(7): e67030.

Time: 2:00 – 13:00 on 12th November

Venue:  MRC CTU in room 401

Directions: See http://www.ctu.mrc.ac.uk/about_us/contact_details.aspx. The entrance is opposite Holborn tube station and looks like the entrance to a church building.

External attendees will need to wait at reception and be taken to the meeting room. If you plan to attend, please contact Patrick Phillips on ppp@ctu.mrc.ac.uk so that reception know who is expected.

Leave a comment

Filed under Uncategorized